Quinolone third-generation

More then a dozen representatives of the above ring systems were introduced into the human therapy. Actisomide (2) and trequinsin (3) are used as antiarrhytmic and antihypertensive agents, respectively. Sunepitron (4), a a 2-adrenoceptor antagonist, is under clinical trials for the treatment of anxiety and depression. Representatives of the third generation of antibacterial quinolone-3-carboxylic acids the blockbluster ofloxacin (5), its levorotatory enantiomer, levofloxacin (6), and rufloxacin (7) have gained wide acceptance for the treatment of bacterial infections of the respiratory and urinary tracts, skin, and soft tissues, as well as sexually transmitted diseases, and pazufloxacin (8) is under development. Praziquantel (9) is widely applied for the treatment of schistosomes- and cestode-caused infection in both veterinary and human therapies (Scheme 4). 

Antibacterial treatment is generally not required in cases of gastroenteritis. Typhoid fever is treated with ciprofloxacin (quinolone), cefotaxime (third generation cephalosporin) or chloramphenicol. Impetigo necessitates the systemic use of flucloxacillin or erythromycin. Topical fusidic acid or mupirocin may also be used. 

Cefalexin is a first-generation cephalosporin and therefore an alternative preparation would be Zinnat tablets, which contains cefuroxime, a second-generation cephalosporin. A penicillin such as Augmentin, which contains co-amoxiclav, can be an appropriate alternative since it provides a very similar spectrum of activity. Klaricid contains clarithromycin, which is a macrolide. Utinor contains norfloxacin, which is a quinolone that is effective in uncomplicated urinary-tract infections. Rocephin contains ceftriaxone, which is a third-generation cephalosporin that is available for parenteral administration only. 

Perhydro derivatives of pyrido[l,2-6][l,2]oxazines are frequently applied in the total synthesis of various alkaloids to control the stereochemistry, and 4-(substituted amino)-5-fluoro-7-oxo derivatives of 3,7-dihydro-2//-pyrido[3,2,l-f7][2,l]benzoxazine- and l,2,3,7-tetrahydropyrido[3,2,l-//]cin-noline-8-carboxylic acids are considered as a subfamily of the third generation of antibacterial quinolones. 

With the advent of potent broad-spectrum antibiotics, such as the quinolones and third-generation cephalosporins, the indications for the use of the polymyxins, with their serious potential for toxicity, are few. Their only justifiable use may be as topical agents. 

Third-generation quinolone >96% excreted unchanged (Stass and Kubitza, 1999). 

Moraxella (Branhamella) catarrhalis TMP-SMZ,1 cephalosporin (second- or third- generation)2 Quinolone,3 macrolide4... 

Salmonella TMP-SMZ, quinolone, cephalosporin (third-generation) Chloramphenicol, ampicillin... 

Although ciprofloxacin for oral and intravenous administration already displayed a very high standard of antibacterial activity and tolerance, some properties still required optimization. These included the need for improved activity against Gram-positive pathogens (e.g., S. pneumoniae) and anaerobic bacteria, and kinetic properties allowing once-daily administration. The properties required by Bayer of the third-generation quinolones were therefore as follows. 

At the start of and during the search for a third-generation quinolone, most of the commercially available quinolones contained an optionally substituted piperazinyl radical in the 7-position (Fig. 14.5). Of these compounds, only norfloxacin, pefloxa-cin, ofloxacin, levofloxacin, ciprofloxacin, enrofloxacin, marbofloxacin, danofloxacin and gatifloxacin still play a role today. The 6,8-difluoroquinolones fleroxacin, spar-floxacin and lomefloxacin, as well as grepafloxacin and temafloxacin, were of little importance or withdrawn from the market due to their adverse side effects [68,69]. 

Gemifloxacin is a third generation, oral broad-spectrum, fluorinated quinolone antibacterial agent. It acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV (TOPO TV), which are essential for cellular replication and bacterial growth [7]. It is... 

Quinolones are divided into "generations" based on their spectrum of activity. The higher the generation, the broader the spectrum of activity. First generation UTIs Second and third generations UTIs, prostatitis, respiratory tract infections, sinusitis, infectious diarrhea, uncomplicated skin and skin structure infections, traveler s diarrhea... 

Patients with documented SBP, positive ascitic fluid cultures, or ascitic fluid PMN count >250 cells/mm, regardless of symptoms, should receive broad-spectrum empiric antibiotic therapy with cefotaxime 2 g every 8 hours, or a similar third-generation cephalosporin. Patients with ascitic fluid PMN counts <250 cells/mm , but with signs and symptoms of infection (abdominal pain, tenderness, fever, encephalopathy, renal failure, acidosis, or peripheral leukocytosis), should also receive empiric antibiotic treatment with cefotaxime 2 g every 8 hours, or a similar third-generation cephalosporin. Outpatient oral therapy of SBP with fluoroquinolones or amoxicillin-clavulanic acid awaits further clinical trials. Short-term inpatient quinolone therapy should be considered for the prevention of SBP in patients with low-protein ascites (<1 g/dL), variceal hemorrhage, or prior SBP. 

Third-generation cephalosporins and quinolones are drugs of choice for the treatment of typhoid fever. The adult dose of chloramphenicol for typhoid fever is 1 g every 6 hours for 4 weeks. 

Sparfioxacin, 5-amino-l-cyclopropyl-7-[(3/ ,55)3,5-dimethylpiperazin-l-yl]-6,8-difluoro-4-oxo-quinolone-3-carboxylic acid, belongs to the third-generation class and is used in veterinary medicine. The TLC-densitometric method was developed... 

---